project id: TCGA-LUAD; case submitter id: TCGA-69-7973; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; rna integrity number: 9.5; age at index: 42; days to birth: -15355; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1969; age at diagnosis: 15355; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IB; ajcc pathologic t: T2a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 230.0; icd 10 code: C34.2; last known disease status: not reported; morphology: 8255/3; primary diagnosis: Adenocarcinoma with mixed subtypes; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Middle lobe, lung; synchronous malignancy: No; tissue or organ of origin: Middle lobe, lung; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; cigarettes per day: 1.36986301369863; pack years smoked: 25.0; is ffpe: false; weight: 40.0; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.6; longest dimension: 0.9; oct embedded: No; shortest dimension: 0.5; portion submitter id: TCGA-69-7973-01A-11; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 5.0; percent necrosis: 2.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 98.0; percent tumor nuclei: 80.0;